Sugi Predict

Sugi Predict / Compounds / SCHEMBL606913

SCHEMBL606913

SCHEMBL606913

OC[C@]1(c2ccccc2)CCCN1c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFB P00751 1/20 0.39
▸ OPRL1 P41146 3/20 0.38
▸ OPRM1 P35372 2/20 0.38
▸ SLC6A9 P48067 1/20 0.38
▸ HSD11B1 P28845 2/20 0.36
▸ NR1H2 P55055 1/20 0.36
▸ NR1H3 Q13133 1/20 0.36
▸ FFAR1 O14842 1/20 0.35
▸ SIGMAR1 Q99720 2/20 0.35
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35
▸ CYP2B6 P20813 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ PRCP P42785 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ GRIN1 Q05586 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ GRIN2A Q12879 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246216 1.00 CFB (0.39) CFBOPRL1OPRM1SLC6A9HSD11B1
SCHEMBL606912 1.00 CFB (0.39) CFBOPRL1OPRM1SLC6A9HSD11B1
SCHEMBL29908655 1.00 CFB (0.39) CFBOPRL1OPRM1SLC6A9HSD11B1
SCHEMBL28282470 0.98 CFB (0.38) CFBOPRL1OPRM1SLC6A9HSD11B1
SCHEMBL9561702 0.98 CFB (0.38) CFBOPRL1OPRM1SLC6A9HSD11B1
Hydrochloric Acid SCHEMBL28274724 0.98 CFB (0.38) CFBOPRL1OPRM1SLC6A9HSD11B1
Hydrochloric Acid SCHEMBL8207460 0.98 CFB (0.38) CFBOPRL1OPRM1SLC6A9HSD11B1
Hydrochloric Acid SCHEMBL9257449 0.98 CFB (0.38) CFBOPRL1OPRM1SLC6A9HSD11B1
SCHEMBL27866641 0.98 CFB (0.38) CFBOPRL1OPRM1SLC6A9HSD11B1
SCHEMBL2190183 0.94 CFB (0.36) CFBOPRL1OPRM1SLC6A9HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 435 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4633638-A1 TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) Luminous Mind Inc. (US) 2025-10-22 — — EP claimed
EP-4615506-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES Sahin, Fikret (TR) 2025-09-17 — — EP claimed
WO-2024258363-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES SAHIN FIKRET (TR) 2024-12-19 — — WO claimed
US-20240207434-A1 METHODS FOR PREPARING CYCLOOCTENES ANDCONJUGATES THEREOF TAGWORKS PHARMACEUTICALS B.V. (NL) 2024-06-27 — — US claimed
WO-2024130044-A1 TREATMENT OF PSYCHOLOGICAL FACTORS AFFECTING OTHER MEDICAL CONDITIONS (PFAOMC) LUMINOUS MIND INC. (US) 2024-06-20 — — WO claimed
CN-113943317-B Preparation method of MeCBS solid 大连双硼医药化工有限公司 2024-02-27 — — CN claimed
CN-117460539-A Methods for preparing cyclooctenes and conjugates thereof 泰克沃尔科斯制药有限公司 2024-01-26 — — CN claimed
EP-4308168-A1 METHODS FOR PREPARING CYCLOOCTENES AND CONJUGATES THEREOF Tagworks Pharmaceuticals B.V. (NL) 2024-01-24 — — EP claimed
CN-114853662-B Process for preparing chiral hydrazinopiperidine derivatives 四川青木制药有限公司 2024-01-12 — — CN claimed
US-20220323380-A1 DRUG COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES ISANAS AG (CH) 2022-10-13 — — US claimed
US-8269039-B2 Amino acids and catalytic preparatory methods WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2012-09-18 — — US claimed
CN-102584795-A Preparing method of crizotinib HONG TANG 2012-07-18 — — CN claimed
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2012-02-16 — — US claimed
CN-102170874-A Compositions and methods for treating psychiatric disorders GOSFORTH CT HOLDINGS PTY LTD 2011-08-31 — — CN claimed
CN-101798326-A Chiral PCN pincerlike metal compound derived from diphenyl prolinol and synthesis method thereof UNIV ZHENGZHOU 2010-08-11 — — CN claimed
US-20090264676-A1 Amino acids and catalytic preparatory methods WARF - WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2009-10-22 — — US claimed
EP-1981831-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF Vaidya, Niteen A. (US) 2008-10-22 — — EP claimed
WO-2007092264-A2 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF VAIDYA NITEEN A (US) 2007-08-16 — — WO claimed
US-20070185346-A1 Kit for automated resolving agent selection and method thereof VAIDYA NITEEN A 2007-08-09 — — US claimed
EP-0453288-A1 Enantiospecific synthesis of S(+)-5,6-dihydro-4-(R-amino)-4H thieno (2,3-B)thiopyran-2-sulfonamide-7,7-dioxide MERCK & CO. INC. (US) 1991-10-23 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120041225-A1 KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF ACKR3, KIT, C3AR1 CFB 690/4885OPRL1 1475/4885OPRM1 1137/4885
US-20240207434-A1 METHODS FOR PREPARING CYCLOOCTENES ANDCONJUGATES THEREOF PAICS, PTMS, MSN CFB 311/4885OPRL1 1722/4885OPRM1 1518/4885
US-20090264676-A1 Amino acids and catalytic preparatory methods DNPEP, PREP, ENPEP CFB 4391/4885OPRL1 2283/4885OPRM1 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.